SyncThink Announces Collaboration with Magic Leap for Eye-Tracking Applications Related to User’s Brain Health
PALO ALTO, Calif., Jan. 8, 2019 — SyncThink, a neuro-technology company with foundational intellectual property in eye-tracking analytics, is collaborating with Magic Leap, a world leader in augmented reality and spatial computing technology, to make their proprietary brain health assessments and therapy applications available on the Magic Leap One platform.
SyncThink will utilize this technology for health assessments, rehabilitation, and sports performance through features such as 3D real-world displays, and a larger set of future features such as gait and body position. SyncThink’s leadership in eye-tracking analytics and ownership of a large-scale clinical database will also be used to augment Magic Leap’s platform capabilities.
“One of the primary advantages of working with Magic Leap’s mixed reality technology is it allows us to create specific interactive brain performance training paradigms in the user’s exact environment instead of trying to produce the same result in a virtual environment,” said CEO of SyncThink Laura Yecies. “This is especially important in sports, for example, where they can train and measure the recovery or improvement of a specific skill by doing the exact activity their sport requires.”
“Magic Leap One is inspired by human physiology and has deep user sensing capabilities that make it an ideal spatial computing platform for developing real-time, objective health and wellness assessments,” said Nicole Samec, Healthcare Product Manager for Magic Leap. “We hope that SyncThink’s use of our platform will enable clinicians, patients, and the general public to optimize their brain health and performance.”
In addition to developing new features and ways to further its brain health assessments in mixed reality, SyncThink will also utilize Magic Leap’s spatial computing platform to make improvements to their full suite of assessments. These additions include adding high-precision methods to objectively assess balance, proprioception, depth perception, and convergence, among others features, for injuries such as concussions.
SyncThink is on a mission to provide objective measurements for brain health and empower people to maximize their health and performance. SyncThink develops revolutionary eye-tracking technology and analytics, in a VR environment, that assist medical professionals in assessing brain health, monitoring recovery, and optimizing performance. With more than 30 published peer-reviewed papers and 12 granted patents, the SyncThink platform uses a series of 60-second assessments to objectively measure eye movements to identify impairments and offers multiple modalities to train dynamic vision. FDA-cleared for detecting eye-tracking impairment and used by leading medical centers such as Stanford and Massachusetts General,the U.S. military, and more than 20 top universities, SyncThink is transforming assessment, recovery, and performance for life and sport. www.syncthink.com